N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.812 NOK 4.38% Market Closed
Market Cap: 918.2m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Wall Street
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 23.052 NOK with a low forecast of 10.1 NOK and a high forecast of 52.5 NOK.

Lowest
Price Target
10.1 NOK
259% Upside
Average
Price Target
23.052 NOK
720% Upside
Highest
Price Target
52.5 NOK
1 767% Upside
Nykode Therapeutics ASA Competitors:
Price Targets
4893
Noile-Immune Biotech Inc
158% Upside
7774
Japan Tissue Engineering Co Ltd
147% Upside
SVE
Synthaverse SA
54% Upside
ALRN
Aileron Therapeutics Inc
418% Upside
002252
Shanghai RAAS Blood Products Co Ltd
8% Downside
4974
Takara Bio Inc
52% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
23% Upside
RCUS
Arcus Biosciences Inc
121% Upside

Revenue
Forecast

Revenue Estimate
Nykode Therapeutics ASA

For the last 6 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 154%. The projected CAGR for the next 3 years is -64%.

154%
Past Growth
-64%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NYKD's stock price target?
Price Target
23.052 NOK

According to Wall Street analysts, the average 1-year price target for NYKD is 23.052 NOK with a low forecast of 10.1 NOK and a high forecast of 52.5 NOK.

What is Nykode Therapeutics ASA's Revenue forecast?
Projected CAGR
-64%

For the last 6 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 154%. The projected CAGR for the next 3 years is -64%.

Back to Top